医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

广告
第一作者: Kayla,Ward
第一单位: School of Medicine and Dentistry, Griffith University - Gold Coast Campus, Southport, Queensland, Australia.;Department of Neurology, Gold Coast University Hospital, Southport, Queensland, Australia.
作者单位: School of Medicine and Dentistry, Griffith University - Gold Coast Campus, Southport, Queensland, Australia.;Department of Neurology, Gold Coast University Hospital, Southport, Queensland, Australia. [1] The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia. [2] Translational Neuroimmunology Group, Kids Neuroscience Centre and ANZAC Research Institute, The University of Sydney Sydney Medical School, Sydney, New South Wales, Australia.;Department of Neurology, Concord Hospital, Concord, New South Wales, Australia. [3] Flinders Medical Centre, Flinders University, Adelaide, South Australia, Australia. [4] Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia. [5] Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. [6] Multiple Sclerosis Australia, Multiple Sclerosis Australia, Summer Hill, New South Wales, Australia. [7] School of Medicine, Griffith University - Gold Coast Campus, Southport, Queensland, Australia.;National Centre for Naturopathic Medicine, Southern Cross University, Lismore, New South Wales, Australia. [8] School of Medicine, Griffith University - Gold Coast Campus, Southport, Queensland, Australia. [9] School of Medicine and Dentistry, Griffith University - Gold Coast Campus, Southport, Queensland, Australia. [10] Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, Australia. [11] Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.;Infection, Immunity and Inflammation Group, School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia. [12] University of Tasmania Menzies Institute for Medical Research, Hobart, Tasmania, Australia. [13] School of Medicine and Dentistry, Griffith University - Gold Coast Campus, Southport, Queensland, Australia.;Rural Health Research Institute, Charles Sturt University, Albury, New South Wales, Australia. [14] QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. [15] Department of Neuroscience, Monash University Central Clinical School, Melbourne, Victoria, Australia. [16] CORe, The University of Melbourne Department of Medicine RMH, Parkville, Victoria, Australia.;Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. [17] Immunology and Infectious Diseases, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia. [18] Multiple Sclerosis Australia, Summer Hill, New South Wales, Australia. [19] Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.;The University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia. [20] Departments of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA. [21] ACORD at MRC Clinical Trials Unit, University College London Institute of Clinical Trials and Methodology, London, UK. [22] ACORD at MRC Clinical Trials Unit, University College London Institute of Clinical Trials and Methodology, London, UK.;NIHR University College London Hospitals Biomedical Research Centre, London, UK.;Queen Square Multiple Sclerosis Centre, Department of Inflammation, UCL Queen Square Institute of Neurology, London, UK. [23] Department of Neurology, Concord Repatriation General Hospital, Concord, New South Wales, Australia.;The University of Sydney Brain and Mind Centre, Camperdown, New South Wales, Australia. [24] Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, Australia.;Department of Neurology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. [25] The University of Sydney Brain and Mind Centre, Camperdown, New South Wales, Australia.;The University of Sydney Sydney Medical School, Sydney, New South Wales, Australia. [26]
DOI 10.1136/bmjno-2025-001313
PMID 41450528
发布时间 2025-12-26
提交
  • 浏览0
BMJ neurology open

BMJ neurology open

2025年7卷2期

e001313页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷